Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation

Antzeko izenburuak

• Coexistence of P190 and P210 BCR/ABL transcripts in chronic myeloid leukemia blast crisis resistant to imatinib
  nork: Junmei, Zhao, et al.
  Argitaratua: (2015)
• Inhibition of Aurora Kinase B Is Important for Biologic Activity of the Dual Inhibitors of BCR-ABL and Aurora Kinases R763/AS703569 and PHA-739358 in BCR-ABL Transformed Cells
  nork: Illert, Anna L., et al.
  Argitaratua: (2014)
• BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase
  nork: Hughes, T P, et al.
  Argitaratua: (2015)
• Detection of twelve nucleotides insertion in the BCR-ABL kinase domain in an imatinib-resistant but dasatinib-sensitive patient with bi-phenotypic acute leukemia
  nork: Hayette, Sandrine, et al.
  Argitaratua: (2009)
• Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia
  nork: Sun, Xiaoyan, et al.
  Argitaratua: (2016)